A non-interventional study (NIS) Registry for the Epidemiological and Scientific evaluation of epidermal growth factor receptor (EGFR) mutation status in patients with newly diagnosed locally advanced or metastatic non small cell lung cancer (NSCLC) (stage IIIB/IV non-small cell lung cancer). - REASON

Study identifier:NIS-OGR-DUM-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An NIS Registry for the Epidemiological and Scientific evaluation of EGFR mutation status in patients with newly diagnosed locally advanced or metastatic NSCLC (stage IIIB/IV non-small cell lung cancer)-REASON STUDY.

Medical condition

Non Small Cell Lung Cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

589

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Oct 2010
Primary Completion Date: 01 Dec 2014
Study Completion Date: 01 Dec 2014

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2015 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria